10% Owner of Pdl Biopharma, Inc. (NASDAQ:PDLI), Silver Point Capital L.P., buys 230,000 shares worth $604,900
According to Pdl Biopharma, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 23 05:50 PM, company 10% Owner, Silver Point Capital L.P. disclosed buying 230,000 shares at a cost of $2.63. At the time of this transaction (Dec 21), this trade was worth $604,900 in total. As of Dec 21, Silver Point Capital L.P. now owns 15,491,460 shares in total worth about $43,066,258.8.
For the last few recent trades made by Pdl Biopharma, Inc. (NASDAQ:PDLI) 10% Owner, Silver Point Capital L.P., we have the following information:
- SEC Form 4 filing: Dec 22: Bought 850,000 shares at the rate of $2.59 per share. Total worth of this trade was $2,201,500. Total number of shares owned as of Dec 22 were 16,341,460
- SEC Form 4 filing: Dec 23: Bought 485,000 shares at the rate of $2.60 per share. Total worth of this trade was $1,261,000. Total number of shares owned as of Dec 23 were 16,826,460
- SEC Form 4 filing: Dec 16: Bought 1,350,000 shares at the rate of $2.58 per share. Total worth of this trade was $3,483,000. Total number of shares owned as of Dec 16 were 14,863,460
Posted by
George Daniels
on Thursday December 24 2020, 10:08 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
